Amgen Profits Rise, Next MariTide Studies Start by Mid-Year
(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key ...
Amgen price target raised to $329 from $310 at Piper Sandler
Piper Sandler raised the firm’s price target on Amgen (AMGN) to $329 from $310 and keeps an Overweight rating on the shares. The firm notes the ...
Reuters10d
Amgen profits rise, next MariTide studies start by mid-year
MariTide Phase 3 studies to begin in first half of year FDA places hold on AMG 513 obesity drug trial Amgen's Q4 earnings beat estimates, revenue up 11% Feb 4 (Reuters) - Amgen (AMGN.O), opens new ...
Investing9d
Amgen profits rise, next MariTide studies start by mid-year
(Reuters) - Amgen (NASDAQ:AMGN) posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key obesity drug candidate MariTide will start before mid-year ...
Yahoo7d
Amgen Stock Has Surged. Here’s Where It’s Headed Next.
All of a sudden, Amgen stock is up 15% since late December ... History Says This Will Happen Next. Super Micro’s finance chief — who is leaving as soon as the company can hire someone more ...
Yahoo Finance16d
Amgen (AMGN) Reports Next Week: Wall Street Expects Earnings Growth
Amgen (AMGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives ...
Seeking Alpha7d
Amgen: Multiple Strengths, But The Valuation Is A Concern
Amgen is a biotechnology leader with competitive ... I expect the ratio to remain relatively stable over the next few years. The firm's free cash flow ("FCF") has risen because of more volume ...